Riskpilot← Back to searchSign inGet full accessCoronaria Medica Oy
OYDissolvedY-tunnus 0581377-2Physiotherapy · NACE 86901Est. 1985— employees
Revenue 2021
EUR 1,6M
+7% vs 2020
EBITDA margin
14.7%
+1% vs 2020
Equity ratio
28.3%
Financial strength
Net profit 2021
EUR 3K
-75% vs 2020
| Revenue | EUR 1,6M | +7% |
| EBITDA | EUR 241K | +1% |
| Net profit | EUR 3K | -75% |
| Total assets | EUR 807K | -12% |
| Equity | EUR 228K | +1% |
| Employees | — | — |
Legal name
Coronaria Medica Oy
Y-tunnus number
0581377-2
Legal form
Osakeyhtiö
NACE code
86901 · Physiotherapy
Founded
17. tammikuuta 1985
Share capital
—
Employees
—
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Revenue | 1 196 | 1 480 | 1 530 | 1 636 |
| Staff expenses | −637 | −686 | −773 | −804 |
| EBITDA | 158 | 296 | 239 | 241 |
| Depreciation & amort. | −25 | −28 | −52 | −66 |
| EBIT | 133 | 268 | 187 | 175 |
| Net financials | −1 | −1 | −4 | −4 |
| Profit before tax | 40 | 107 | 47 | 37 |
| Tax | 35 | 55 | 36 | 34 |
| Net profit | 5 | 53 | 11 | 3 |
| Item | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Total assets | 574 | 862 | 918 | 807 |
| Equity | 314 | 215 | 226 | 228 |
| Long-term debt | — | 245 | 245 | 163 |
| Short-term debt | 260 | 402 | 447 | 416 |
| Total debt | 260 | 647 | 692 | 579 |
EBITDA margin
14.7%
This company
15.8%
Market median
-7% vs market
20182021
Equity ratio
28.3%
This company
38.2%
Market median
-26% vs market
20182021
Return on equity
1.2%
This company
18.4%
Market median
-93% vs market
20182021
Net profit margin
0.2%
This company
8.1%
Market median
-98% vs market
20182021
Asset turnover
2.03×
This company
1.12×
Market median
+81% vs market
20182021
Debt / equity
2.53×
This company
0.62×
Market median
-308% vs market
20182021
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
SK Deputy Member | Deputy Member | 2017 – 2019 |
SS | Audit | 2017 – 2023 |
AE Chief Executive Officer | Chief Executive Officer | 2017 – 2021 |
AA Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Board of Directors | 2019 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Coronaria Medica Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sanna Kristiina Jussila | Deputy Member | 0 companies |
| Sami Seppo Sakari Posti | Audit | 0 companies |
| Anu Elina Uutela | Chief Executive Officer | 0 companies |
| Arto Antero Lamberg | Chief Executive Officer | 0 companies |
| Teppo Emil Linden | Board of Directors | 0 companies |